NCT00116116View on ClinicalTrials.gov

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
HIV InfectionsAIDS
Interventions
DRUG

efavirenz, stavudine extended release, lamivudine

Trial Locations (10)

Unknown

Local Institution, Bakersfield

Local Institution, San Francisco

Local Institution, Washington D.C.

Local Institution, Fort Lauderdale

Local Institution, Jacksonville

Local Institution, Miami

Local Institution, New York

Local Institution, Greenville

Local Institution, Oklahoma City

Local Institution, Dallas

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00116116 - DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy | Biotech Hunter | Biotech Hunter